2017

Discovery of potent NEK2 inhibitors as potential anticancer agents using structure-based exploration of NEK2 pharmacophoric space coupled with QSAR analyses

mkhanfar, 645, Journal Article, , Discovery of potent NEK2 inhibitors as potential anticancer agents using structure-based exploration of NEK2 pharmacophoric space coupled with QSAR analyses. (2017). Molecular Diversity, 21, 187–200.

2017

Chronic kidney disease impairs renal nerve and haemodynamic reflex responses to vagal afferent input through a central mechanism

isalman, 854, Journal Article, , Chronic kidney disease impairs renal nerve and haemodynamic reflex responses to vagal afferent input through a central mechanism. (2017). Autonomic Neuroscience 204, 65-73, 2017, 204, 65-73. (Original work published 2017)

2017

Discovery of potent Bruton’s tyrosine kinase inhibitors using ligand based modeling

mkhanfar, 645, Journal Article, , Discovery of potent Bruton’s tyrosine kinase inhibitors using ligand based modeling. (2017). Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017, 17, 265–275.

2017

Discovery of Potent Bruton’s Tyrosine Kinase Inhibitors Using Ligand Based Modeling

mkhanfar, 645, Journal Article, , Discovery of Potent Bruton’s Tyrosine Kinase Inhibitors Using Ligand Based Modeling. (2017). Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 17, 265–275.

2017

Proteinease inhibition, membrane stabilization, antioxidant and phytochemical evaluations of leaves, seeds and calyces of four selected edible medicinal plants

amustapha, 990, Journal Article, , Proteinease inhibition, membrane stabilization, antioxidant and phytochemical evaluations of leaves, seeds and calyces of four selected edible medicinal plants. (2017). Cogent Chemistry 3 (1), 1314064, 2017.

2017

6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer

mkhanfar, 645, Journal Article, , 6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer. (2017). Medicinal Chemistry Research 26 (7), 1397-1404, 2017, 26, 1397–1404.

2017

6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer

mkhanfar, 645, Journal Article, , 6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer. (2017). Medicinal Chemistry Research, 26, 1397–1404.

2017

Abstract P110: low Intensity stimulation of Aortic Baroreceptors as a potential therapeutic alternative for hypertension treatment

isalman, 854, Journal Article, , Abstract P110: low Intensity stimulation of Aortic Baroreceptors as a potential therapeutic alternative for hypertension treatment. (2017). Hypertension 70 (suppl_1), AP110-AP110, 2017.

2017

Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors

mkhanfar, 645, Journal Article, , Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors. (2017). Journal of Molecular Recognition 30 (9), e2623, 2017, 30, e2623.

2017

A prodrug approach to enhance azelaic acid percutaneous availability

mkhanfar, 645, Journal Article, , A prodrug approach to enhance azelaic acid percutaneous availability. (2017). Pharmaceutical Development and Technology 22 (4), 578-586, 2017, 22, 578–586.